Application of hypoxia-adjustable promoter in CAR-T

A promoter and late promoter technology, applied in the direction of animal cells, vertebrate cells, genetically modified cells, etc., can solve the problems that affect the efficacy of CAR-T cells, the effect is not as good as that of blood system tumors, and CAR-T is difficult

Pending Publication Date: 2020-09-22
CHONGQING PRECISION BIOTECH CO LTD
View PDF5 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] The full name of CAR-T is chimeric antigen receptor T cell immunotherapy, which has achieved good results in hematological tumors, but the effect of CAR-T in solid tumors is not as good as that of hematological tumors. It is difficult to enter the interior of solid tumors. On the one hand, even if CAR-T cells enter the interior of solid tumors, they cannot function normally due to the tumor microenvironment. These all affect the efficacy of CAR-T cells in the treatment of solid tumors; High, solid tumor targets are often expressed in normal tissues, so there are safety issues such as off-target risks
Although there are currently constructions of fourth-generation CARs, dual CARs (constructing CAR-T with dual antigens) or iCARs with activation and inhibition functions in order to improve the effectiveness and safety of tumor CAR-T therapy, but These CAR structures still have problems of safety or difficulty in being activated

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of hypoxia-adjustable promoter in CAR-T
  • Application of hypoxia-adjustable promoter in CAR-T
  • Application of hypoxia-adjustable promoter in CAR-T

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0086] Embodiment 1 plasmid construction

[0087] The plasmids were constructed according to the conditions shown in Table 2 for subsequent experiments. The plasmids were constructed using the mini promoter miniCMV, lentiviral expression vector, antigen recognition region CD19 and PSCA as examples.

[0088] The synthetic hypoxia promoter sequence 5HRE-CMVmini promoter nucleotide sequence is shown in SEQ ID NO: 1, and the promoter EcoRV-5HRE-CMVmini promoter-NheI (5H1P) matched with the lentiviral vector is further constructed, and the nucleotide sequence is shown in SEQ ID NO: 2 As shown, the targeted PSCA-CAR nucleic acid sequence is shown in SEQ ID NO:3, and the amino acid sequence is shown in SEQ ID NO:5; the targeted CD19-CAR nucleic acid sequence is shown in SEQ ID NO:4, and the amino acid sequence is shown in SEQ ID NO:4 Shown in ID NO:6; Targeted CEA-CAR amino acid sequence is shown in SEQ ID NO.42. The fragments were cut and recovered by double enzyme digestion, the g...

Embodiment 2

[0092] Example 2 In vitro hypoxia model verification

[0093] CoCl 2 Induced hypoxia principle: cobalt dichloride (CoCl 2 ) in the divalent cobalt ions (Co2+) can replace the PHD cofactor divalent iron ions, because Co2+ has a low affinity for oxygen, so that heme cannot combine with oxygen and cannot change into an oxidized state, thus forming a hypoxic state.

[0094] 1) Hypoxia induction scheme verification:

[0095] PBKL1-5HRE-GFP virus infected and activated PBMCs were used to construct hypoxic cell models in vitro, and the medium was changed after 12-18 hours of culture. Using CoCl 2 Induce a hypoxic environment, and cultivate until the 4th day to verify whether the hypoxic model has been constructed by green fluorescence detection, and set up the control group (without CoCl 2 ), the experimental group (plus CoCl 2 ), CoCl 2 After 24 hours of drug treatment, fluorescent microscope photographs were taken to detect the expression intensity of GFP, and the positive ra...

Embodiment 3

[0099] Example 3 Preparation of lentivirus and infection of T lymphocytes

[0100] In this example, the calcium phosphate method was used to package the lentivirus, specifically: 293T cells were cultured in DMEM medium to an optimal state, and the cells were replaced in advance. Add the packaging plasmid (RRE:REV:2G) and the expression plasmid to a 1.5 centrifuge tube in a certain ratio, and add 2.5mol / LCaCl 2 , add ddH 2 O to a total volume of 600 μL, mix well, and add 2×HBS dropwise to the mixture with a pipette, mix well, let stand at room temperature for 15 minutes, add to the treated 293T cell culture medium, and change again after 3-5 hours Liquid to 10mL DMEM medium containing 10% FBS, after 48h or 72h, the cell supernatant was collected, the virus was purified, and the titer was determined.

[0101] Lymphocytes were separated by gradient centrifugation; after centrifugation, the second white lymphocyte layer was taken, washed with saline, and cultured in RPMI 1640 co...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of immunotherapy, and particularly relates to application of a hypoxia-adjustable promoter in CAR-T, a CAR structure of the hypoxia-adjustable promoter, anexpression vector, CAR-T cells, application of the CAR-T cells, a method for improving the IFN-gamma and/or IL-2 factor secretion capacity of the CAR-T cells in a hypoxia environment, and a method for improving the CAR-T cell killing capacity in the hypoxia environment. The CAR structure contains the hypoxia-adjustable promoter, the hypoxia-adjustable promoter is formed by connecting Hif1a adjusting elements and mini promoters, and the number of repetitions of the Hif1a adjusting elements is 3-5. The CAR structure induced and started by the hypoxia microenvironment not only can be effectivelyexpressed in T lymphocytes, but also can enhance the activation of the CAR-T cells in the hypoxia environment and enhance the effectiveness and safety of the CAR-T, and can be used for targeted therapy of tumors.

Description

technical field [0001] The invention belongs to the technical field of immunotherapy, and specifically relates to the application of a hypoxia-regulatable promoter in CAR-T, a CAR structure of a hypoxia-regulatable promoter, an expression vector, CAR-T cells and applications thereof As well as a method for improving the ability of CAR-T cells to secrete IFN-γ and / or IL-2 factors in a hypoxic environment and a method for improving the killing ability of CAR-T cells in a hypoxic environment. Background technique [0002] The full name of CAR-T is chimeric antigen receptor T cell immunotherapy, which has achieved good results in hematological tumors, but the effect of CAR-T in solid tumors is not as good as that of hematological tumors. It is difficult to enter the interior of solid tumors. On the one hand, even if CAR-T cells enter the interior of solid tumors, they cannot function normally due to the tumor microenvironment. These all affect the efficacy of CAR-T cells in the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K35/17C07K19/00C12N5/10C12N15/63A61P35/00A61P35/02
CPCA61K35/17C07K14/7051C07K16/30C12N5/0636A61P35/00A61P35/02C07K2319/33C12N2510/00
Inventor 张巍朱秀秀赵永春赵文旭陈军黄霞
Owner CHONGQING PRECISION BIOTECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap